Weiss L, Marbet C, Branca L, Muhleisen B, Navarini A
Case Rep Dermatol. 2024; 16(1):144-148.
PMID: 39015397
PMC: 11250620.
DOI: 10.1159/000539124.
Perera J, Delrosso C, Nerviani A, Pitzalis C
Cells. 2024; 13(9.
PMID: 38727279
PMC: 11083059.
DOI: 10.3390/cells13090743.
Trave I, Salvi I, Burlando M, Cozzani E, Parodi A
J Clin Med. 2023; 12(19).
PMID: 37834935
PMC: 10573833.
DOI: 10.3390/jcm12196291.
Landgren A, Jonsson C, Bilberg A, Eliasson B, Torres L, Dehlin M
Arthritis Res Ther. 2023; 25(1):131.
PMID: 37501212
PMC: 10373368.
DOI: 10.1186/s13075-023-03105-8.
Kim J, Lee J, Huh Y, Kim K, Chaparala V, Krueger J
J Invest Dermatol. 2023; 144(1):43-52.e6.
PMID: 37419444
PMC: 11060321.
DOI: 10.1016/j.jid.2023.06.194.
Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review.
Su Z, Zeng Y
Dermatology. 2023; 239(4):646-657.
PMID: 37100035
PMC: 10407831.
DOI: 10.1159/000530608.
Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report.
Gelato F, Mastorino L, Cavalla P, Quaglino P, Cavaliere G, Vercellino M
Dermatol Ther. 2022; 35(10):e15740.
PMID: 35899485
PMC: 9788158.
DOI: 10.1111/dth.15740.
Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases.
Miyagawa F
Biomedicines. 2022; 10(7).
PMID: 35884790
PMC: 9312477.
DOI: 10.3390/biomedicines10071485.
Study of Hypersensitivity to in Patients with Atopic Dermatitis with Head and Neck Pattern: Is It Useful as a Biomarker and Therapeutic Indicator in These Patients?.
Navarro-Trivino F, Ayen-Rodriguez A
Life (Basel). 2022; 12(2).
PMID: 35207586
PMC: 8876740.
DOI: 10.3390/life12020299.
Pyoderma gangrenosum developing in a patient treated with dupilumab.
Nasseh J, Abi Rached H, Dumitru I, Staumont-Salle D, Dezoteux F
JAAD Case Rep. 2022; 20:58-60.
PMID: 35097179
PMC: 8783112.
DOI: 10.1016/j.jdcr.2021.12.009.
Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab.
Laageide L, Verhave B, Samkoff L, Looney R, Beck L
JAAD Case Rep. 2021; 15:33-35.
PMID: 34401425
PMC: 8349746.
DOI: 10.1016/j.jdcr.2021.07.003.
New Biologics for the Treatment of Atopic Dermatitis: Analysis of Efficacy, Safety, and Paradoxical Atopic Dermatitis Acceleration.
Qi H, Li L
Biomed Res Int. 2021; 2021:5528372.
PMID: 34195265
PMC: 8181104.
DOI: 10.1155/2021/5528372.
